2023. Formulation and Evaluation of Orodispersible Tablet Containing Combination of Phosphodiesterase-5 Inhibitor and Herbal Aphrodisiac. International Journal of Ayurveda and Pharma Research. 11, 2 (Mar. 2023), 13–30. DOI:https://doi.org/10.47070/ijapr.v11i2.2700.